By mining the existing human bladder cancer databases, we found that the high levels of expression of several activators within our identified SNHG1 effector pathway were strongly associated with poor patient survival; these activators may serve as actionable targets during therapies to control bladder cancer invasion and metastasis. Here, SNHG1 is linked to urinary bladder cancer.